Neisseria gonorrhoeae in Newcastle upon Tyne 1995-1997: Increase in ciprofloxacin resistance

International Journal of STD and AIDS

Volumn 10, Issue 5, 1999, Pages 290-293

  Tayal, S C ^a,b   Sankar, K N ^a   Pattman, R S ^a   Watson, P G ^a   Galloway, A ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Ciprofloxacin; Neisseria gonorrhoeae; Resistance; Treatment failure

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN; PENICILLIN G; SPECTINOMYCIN; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; FEMALE; GONORRHEA; HETEROSEXUALITY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED KINGDOM;

ADULT; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, MICROBIAL; ENGLAND; FEMALE; GONORRHEA; HETEROSEXUALITY; HOMOSEXUALITY, MALE; HUMANS; MALE; MIDDLE AGED; NEISSERIA GONORRHOEAE;

EID: 0032923819     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462991914131     Document Type: Article

References (33)

1. Centers for Disease Control. Tetracycline-resistant Neisseria gonorrhoeae - Georgia, Pennsylvania, New Hampshire. MMWR 1985;34:563-70
2. Ison C, Terry P, Bendayna K, Gill M, Adam J. Tetracycline resistant gonococci in UK. Lancet 1988;1:651-2
3. Van Dyck E, Rossau R, Duhamel M, et al. Antimicrobial susceptibility of Neisseria gonorrhoeae in Zaire: high level plasmid-mediated tetracycline resistance in central Africa. Genitorurin Med 1992;68:111-16
4. Centers for Disease Control. Gonorrhoea: Antimicrobial Resistance. Http://www.cdc.gov/ncidod/dastlr/Resist/ diskdif.html/, Anonymous 1998
5. Corkhill JE, Percival A, Lind M. Reduced uptake of ciprofloxacin in a resistant strain of Neisseria gonorrhoeae and transformation of resistance to other strains. J Antimicrob Chemother 1991;28:601-4
6. Centers for Disease Control and Prevention. Fluoroquinolone resistance in Neisseria gonorrhoeae - Colorado and Washington. MMWR 1995;44:761-4
7. Tapsall JW, Phillips EA, Shultz TR, Thacker C. Quinolone-resistant Neisseria gonorrhoeae isolated in Sydney, Australia 1991 to 1995. Sex Transm Dis 1996;23:425-8
8. Kam KM, Wong PW, Cheung MM, Ho NKY, Lo KK. Quinolone resistant Neisseria gonorrhoeae in Hong Kong. Sex Transm Dis 1996;23:103-8
9. Knapp JS, Mesola VP, Neal SW, et al. Molecular epidemiology, in 1994, of Neisseria gonorrhoeae in Manila and Cebu City, Republic of the Philippines. Sex Transm Dis 1997;24:2-7
10. Ng PPL, Chan RKW, Ling AE. Gonorrhoea treatment failure and ciprofloxacin resistance. Int J STD AIDS 1998;9:323-5
11. Rattan A, Kumari S, Khanna N, et al. Emergence of fluoroquinolone resistant Neisseria gonorrhoeae in New Delhi, India. Sex Transm Dis 1998;74:229
12. Knapp JS, Washington JA, Doyle LJ, Neal SW, Parekh MC, Rice RJ. Persistance of Neisseria gonorrhoeae strains with decreased susceptibilities to ciprofloxacin and ofloxacin in Cleveland, Ohio, from 1992 through 1993. Antimicrob Agents Chemother 1994;38:2194-6
13. Antimicrobial chemotherapy. In: Bannister BA, Begg NT, Gillespie SH, eds. Infectious Disease. Oxford: Blackwell Science Ltd, 1996:53
14. Belland RJ, Morrison SG, Ison C, Huang WM. Neisseria gonorrhoeae acquires mutations in analogous regions of gyr A, parC in fluoroquinolone-resistant isolates. Mol Microbiol 1994;14:371-80
15. Stein DC, Danaher RJ, Cook TM. Characterization of a gyrB mutation responsible for low level nalidixic acid resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother 1991;35:622-6
16. Deguchi TM, Yasuda M, Asano M, et al. DNA gyrase mutations in fluoroquinolone-resistant clinical isolates in Neisseria gonorrhoeae. Antimicrob Agents Chemother 1995;39:561-3
17. Deguchi TM, Yasuda M, Nakano M, et al. Quinolone resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles. Antimicrob Agents Chemother 1996;40:1020-3
18. Corkill JE, Percival A, Lind M. Reduced uptake of ciprofloxacin in a resistant strain of Neisseria gonorrhoeae and transformation of resistance to other strains. J Antimicrob Chemother 1991;28:601-4
19. Knapp JS, Fox KK, Trees DL, Whittington WL. Fluoroquinolone resistance in Neisseria gonorrhoeae. Emerg Infect Dis 1997;3:33-9
20. Faruki H, Kohmescher RN, McKinney WP, Sparling PF. A community based outbreak of infection with penicillin resistant Neisseria gonorrhoeae not producing penicillinase (chromosomally mediated resistance). N Engl J Med 1985;313:607-11
21. Oriel JD. Ciprofloxacin in the treatment of gonorrhoea and non-gonococcal urethritis. J Antimicrob Chemother 1986;18(suppl D):129-32
22. Loo PS, Ridgeway GL, Oriel JD. Single dose ciprofloxacin for treating gonococcal infection in men. Genitourin Med 1985;61:302-5
23. Shahmanesh M, Shukla SR, Philips I, Westwood A, Thin RW. Ciprofloxacin for treating urethral gonorrhoea in men. Genitourin Med 1986;62:86-7
24. Scott GR, McMillan A, Young H. Ciprofloxacin versus ampicillin and probencid in the treatment of uncomplicated gonorrhoea in men. J Antimicrob Chemother 1987;20:117-21
25. Gransden WR, Warren CA, Philips I, Hodges M, Barlow D. Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacin [Letter]. Lancet 1990;335:51
26. Tapsall JW, Lovett R, Munro R. Failure of 500 mg ciprofloxacin therapy in male urethral gonorrhoea. Med J Aust 1992;156:143
27. Birley H, MacDonald P, Carey P, Fletcher J. High level ciprofloxacin resistance in Neisseria gonorrhoeae. Genitourin Med 1994;70:292-3
28. Kam KM, Lo KK, Ng KYH, et al. Rapid decline in penicillinase-producing Neisseria gonorrhoeae in Hong Kong associated with emerging 4-fluoroquinolone resistance. Genitourin Med 1995;71:141-4
29. Turner A, Gough KR, Jephcott AE, Mclean AN. Importation in to the UK of a strain of Neisseria gonorrhoeae resistant to penicillin, ciprofloxacin and tetracycline. Genitourin Med 1995;71:265-9
30. O'Mahony C, Timmins D. Treatment failure using double dose ciprofloxacin in case of highly resistant gonorrhoea. Genitourin Med 1992;68:274-5
31. Turner A, Jephcott AE, Haji TC, Gupta PC. Ciprofloxacin resistant Neisseria gonorrhoeae in the UK. Genitourin Med 1990;66:43
32. Simms I, Hughes G, Swan AV, Rogers PA, Catchpole M. New cases seen at genitourinary medicine clinics: England 1996. Commun Dis Rep CDR 1998;8(suppl 1):S1-S11
33. Standing Medical Advisory Committee Sub-Group on Antimicrobial resistance. Synopsis - The Path of Least Resistance. London: Department of Health, September 1998:3-65